Literature DB >> 25706527

Vaccines for Patients with COPD.

Dolores Moreno, Judith Barroso, Alexis Garcia1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by chronic obstruction of lung airflow limitation. This disease is currently the fourth higher cause of death in the world, and it is predicted to be the third by the year 2020. Patients with COPD are frequently exposed to Human Rhinovirus, Respiratory Syncytial and Influenza Virus, as well as to Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. These infectious agents are responsible for exacerbations increasing morbidity and mortality in COPD patients. Prevention of infectious exacerbations by vaccination would improve quality of life and patient survival. A literature search: "vaccination of COPD patients" was performed using Medline, the Cochrane Library and other Non-Indexed Citations for this review. This article presents a brief overview of the different studies found, on the new patents, and the future strategies on the field.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25706527     DOI: 10.2174/1872213x09666150223114958

Source DB:  PubMed          Journal:  Recent Pat Inflamm Allergy Drug Discov        ISSN: 1872-213X


  3 in total

1.  Risk factors associated with physical and mental distress in people who report a COPD diagnosis: latent class analysis of 2016 behavioral risk factor surveillance system data.

Authors:  Michael Stellefson; Samantha R Paige; Adam E Barry; Min Qi Wang; Avery Apperson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-04-10

2.  2018 recommendations for the management of community acquired pneumonia.

Authors:  Ricardo de Amorim Corrêa; Andre Nathan Costa; Fernando Lundgren; Lessandra Michelin; Mara Rúbia Figueiredo; Marcelo Holanda; Mauro Gomes; Paulo José Zimermann Teixeira; Ricardo Martins; Rodney Silva; Rodrigo Abensur Athanazio; Rosemeri Maurici da Silva; Mônica Corso Pereira
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

3.  Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.

Authors:  Min Li; Guang-Chao Han; Yang Chen; Wen-Xiu Du; Fang Liu; Yu-Min Chi; Jun-Feng Du
Journal:  Braz J Med Biol Res       Date:  2020-11-27       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.